95 related articles for article (PubMed ID: 17917966)
1. Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy.
He H; Cheng L; Weiss LM; Chu PG
Leuk Lymphoma; 2007 Oct; 48(10):1976-80. PubMed ID: 17917966
[TBL] [Abstract][Full Text] [Related]
2. Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases.
Chu PG; Huang Q; Weiss LM
Am J Surg Pathol; 2005 May; 29(5):693-9. PubMed ID: 15832096
[TBL] [Abstract][Full Text] [Related]
3. Incidental small lymphocytic lymphoma/chronic lymphocytic leukemia in pelvic lymph nodes excised at radical prostatectomy.
Weir EG; Epstein JI
Arch Pathol Lab Med; 2003 May; 127(5):567-72. PubMed ID: 12708899
[TBL] [Abstract][Full Text] [Related]
4. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
[TBL] [Abstract][Full Text] [Related]
5. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer.
Eisenberger CF; Walsh PC; Eisenberger MA; Chow NH; Partin AW; Mostwin JL; Marshall FF; Epstein JI; Schoenberg M
Urology; 1999 Jan; 53(1):175-9. PubMed ID: 9886608
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma diagnosed from radical prostatectomy for prostate adenocarcinoma: a case report.
Tvrdíková E; Křen L; Kubolková AS; Pacík D
Cesk Patol; 2019; 55(4):231-234. PubMed ID: 31842554
[TBL] [Abstract][Full Text] [Related]
7. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
Kibel AS; Rosenbaum E; Kattan MW; Picus J; Dreicer R; Klein EA; Chatta GS; Nelson JB; DiPaola RS; Roth BJ; Cookson MS; Wilding G; Jarrard DF; Beer TM; Ryan CW; Petrylak DP; Benson MC; Partin AW; Garrett-Mayer E; Eisenberger MA
J Urol; 2007 May; 177(5):1777-81. PubMed ID: 17437819
[TBL] [Abstract][Full Text] [Related]
9. Hematolymphoid malignancies diagnosed at the time of radical prostatectomy.
Terris MK; Hausdorff J; Freiha FS
J Urol; 1997 Oct; 158(4):1457-9. PubMed ID: 9302142
[TBL] [Abstract][Full Text] [Related]
10. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
[TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy in patients with incidental prostate carcinoma.
Manseck A; Wirth M; Theiss M; Frohmüller H
Urol Int; 1994; 53(4):196-208. PubMed ID: 7531896
[TBL] [Abstract][Full Text] [Related]
12. Incidental findings in pelvic lymph nodes at radical prostatectomy.
Winstanley AM; Sandison A; Bott SR; Dogan A; Parkinson MC
J Clin Pathol; 2002 Aug; 55(8):623-6. PubMed ID: 12147660
[TBL] [Abstract][Full Text] [Related]
13. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
[TBL] [Abstract][Full Text] [Related]
14. Five-year prognosis after radical prostatectomy in a patient with localized prostate cancer and incidental non-Hodgkin's lymphoma.
Drinis S; Finkelstein MP; Tortorelis DG; Konno S; Choudhury MS
Urol Int; 2001; 66(2):105-7. PubMed ID: 11223753
[TBL] [Abstract][Full Text] [Related]
15. [Long-term outcomes of prostate cancer patients with lymph nodes metastasis after radical prostatectomy and pelvic lymph node dissection].
De Vergie S; Gaschignard N; Baron M; Branchereau J; Luyckx F; Butel T; Perrouin-Verbe MA; Bouchot O; Rigaud J
Prog Urol; 2018 Jan; 28(1):25-31. PubMed ID: 29221663
[TBL] [Abstract][Full Text] [Related]
16. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
18. Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy.
Yamamoto S; Kawakami S; Yonese J; Fujii Y; Urakami S; Masuda H; Numao N; Ishikawa Y; Kohno A; Fukui I
Jpn J Clin Oncol; 2012 Jun; 42(6):541-7. PubMed ID: 22457326
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of prostatic incidental carcinoma].
Saito K; Takahashi T; Nomura S
Hinyokika Kiyo; 1989 Aug; 35(8):1347-53. PubMed ID: 2479236
[TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Bader P; Burkhard FC; Markwalder R; Studer UE
J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
